Twist Bioscience COO Patrick Weiss steps down; internal promotions announced

Twist Bioscience Corp

Patrick Weiss resigns as COO effective April 21, 2022, for personal reasons; will stay as strategic advisor.
Tracey Mullen promoted to SVP of Operations; she joined via the Abveris acquisition in November 2021.
Nimisha Srivastava promoted to SVP of R&D; she has been with Twist since 2014, leading engineering.
Company initiates formal search for a new COO.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Patrick Weiss

Chief Operating Officer

TWST · Twist Bioscience Corp

Effective: 2022-04-21
Filed: April 22, 2022, 7:59 PM ET

On April 20, 2022, Patrick Weiss notified Twist Bioscience Corporation (the “Company”) that he is stepping down as the Company’s Chief Operating Officer effective April 21, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick Weiss departed as Chief Operating Officer at Twist Bioscience Corp.

Action: stepping down
Role: Chief Operating Officer

Exact text from the filing

On April 20, 2022, Patrick Weiss notified Twist Bioscience Corporation (the “Company”) that he is stepping down as the Company’s Chief Operating Officer effective April 21, 2022.

View on SEC.gov

Twist Bioscience Corp filing history →

Source: SEC EDGAR

accession 0001104659-22-048997

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.